Host CD4+ CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT

被引:38
作者
Bayer, Allison L. [1 ,2 ]
Jones, Monica [1 ]
Chirinos, Jackeline [1 ]
de Armas, Lesley [1 ]
Schreiber, Taylor H. [1 ]
Malek, Thomas R. [1 ,2 ]
Levy, Robert B. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Immunol & Med Microbiol, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA
基金
美国国家卫生研究院;
关键词
BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; REGULATORY CELLS; LETHAL AUTOIMMUNITY; DISEASE; GRAFT; INTERLEUKIN-2; TOLERANCE; MICE; REGENERATION;
D O I
10.1182/blood-2008-08-173179
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reconstitution of the recipient lymphoid compartment following hematopoietic cell transplantation (HCT) is typically delayed. The present studies investigated the residual host CD4(+) CD25(+) Foxp3(+) (Treg) compartment after several conditioning regimens, including T cell depleted and T cell-replete HCT and observed (1) a small number of recipient Treg cells survived aggressive conditioning; (2) the surviving, that is, residual Tregs underwent marked expansion; and (3) recipient CD4(+) FoxP3(+) cells composed the majority of the Treg compartment for several months post-syngeneic HCT. Notably, residual Tregs also dominated the compartment post-HCT with T cell depleted (TCD) major histocompatibility complex-matched allogeneic bone marrow but not following T cell-replete transplantations. The residual Treg cell compartment was functionally competent as assessed by in vitro lymphoid suppression and in vivo autoimmune disease transfer assay. These observations support the notion that functional host Tregs initially occupy a niche in lymphopenic transplantation recipients, undergo significant expansion, and contribute to the compartment for an extended period before donor-derived CD4(+)FoxP3(+) T cells eventually compose the majority of the compartment. In total, the findings suggest that the presence of host Tregs may be important to consider regarding elicitation of immune (eg, antitumor, vaccine) responses in recipients during the early post-transplant period involving autologous and certain allogeneic HCT regimens. (Blood. 2009; 113: 733-743)
引用
收藏
页码:733 / 743
页数:11
相关论文
共 50 条
[1]   Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells [J].
Barao, I ;
Hanash, AM ;
Hallett, W ;
Welniak, LA ;
Sun, K ;
Redelman, D ;
Blazar, BR ;
Levy, RB ;
Murphy, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5460-5465
[2]   Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period [J].
Bayer, AL ;
Yu, AX ;
Adeegbe, D ;
Malek, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :769-777
[3]   Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells [J].
Bayer, Allison L. ;
Yu, Aixin ;
Malek, Thomas R. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4062-4071
[4]   CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia [J].
Bourgeois, Christine ;
Stockinger, Brigitta .
JOURNAL OF IMMUNOLOGY, 2006, 177 (07) :4558-4566
[5]   Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma [J].
Buadi, F. K. ;
Micallef, I. N. ;
Ansell, S. M. ;
Porrata, L. F. ;
Dispenzieri, A. ;
Elliot, M. A. ;
Gastineau, D. A. ;
Gertz, M. A. ;
Lacy, M. Q. ;
Litzow, M. R. ;
Tefferi, A. ;
Inwards, D. J. .
BONE MARROW TRANSPLANTATION, 2006, 37 (11) :1017-1022
[6]  
BUTTURINI A, 1986, BLOOD, V68, P954
[7]   Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies [J].
Chen, Xiaohua ;
Hale, Gregory A. ;
Barfield, Raymond ;
Benaim, Ely ;
Leung, Wing H. ;
Knowles, James ;
Horwitz, Edwin M. ;
Woodard, Paul ;
Kasow, Kimberly ;
Yusuf, Usman ;
Behm, Frederick G. ;
Hayden, Randall T. ;
Shurtleff, Sheila A. ;
Turner, Victoria ;
Srivastava, Deo Kumar ;
Handgretinger, Rupert .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (04) :524-532
[8]   High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma [J].
Child, JA ;
Morgan, GJ ;
Davies, FE ;
Owen, RG ;
Bell, SE ;
Hawkins, K ;
Brown, J ;
Drayson, MT ;
Selby, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1875-1883
[9]   Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis [J].
Cox, AL ;
Thompson, SAJ ;
Jones, JL ;
Robertson, VH ;
Haley, G ;
Waldmann, H ;
Compston, DAS ;
Coles, AJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (11) :3332-3342
[10]  
Cui Y. F., 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P159